Envestnet Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.11M Buy
27,377
+769
+3% +$87.4K ﹤0.01% 2523
2025
Q1
$2.8M Sell
26,608
-60,587
-69% -$6.37M ﹤0.01% 2505
2024
Q4
$9.34M Buy
87,195
+910
+1% +$97.5K ﹤0.01% 1698
2024
Q3
$8.64M Buy
86,285
+6,673
+8% +$668K ﹤0.01% 1736
2024
Q2
$6.71M Buy
79,612
+25,717
+48% +$2.17M ﹤0.01% 1825
2024
Q1
$3.94M Buy
53,895
+8,775
+19% +$641K ﹤0.01% 2140
2023
Q4
$3.22M Buy
45,120
+1,332
+3% +$95.1K ﹤0.01% 2172
2023
Q3
$2.62M Buy
43,788
+5,916
+16% +$354K ﹤0.01% 2217
2023
Q2
$2.73M Sell
37,872
-34,423
-48% -$2.48M ﹤0.01% 2085
2023
Q1
$2.37M Buy
72,295
+41,784
+137% +$1.37M ﹤0.01% 2086
2022
Q4
$2.04M Sell
30,511
-17,882
-37% -$1.19M ﹤0.01% 2153
2022
Q3
$2.6M Buy
48,393
+5,724
+13% +$308K ﹤0.01% 1922
2022
Q2
$2.38M Buy
42,669
+4,954
+13% +$276K ﹤0.01% 1998
2022
Q1
$2.65M Buy
37,715
+3,117
+9% +$219K ﹤0.01% 2038
2021
Q4
$3.33M Buy
34,598
+8,705
+34% +$839K ﹤0.01% 1842
2021
Q3
$2.25M Buy
25,893
+1,659
+7% +$144K ﹤0.01% 2020
2021
Q2
$1.98M Buy
24,234
+7,935
+49% +$649K ﹤0.01% 2061
2021
Q1
$1.55M Sell
16,299
-5,303
-25% -$504K ﹤0.01% 2102
2020
Q4
$1.34M Sell
21,602
-15,400
-42% -$955K ﹤0.01% 2012
2020
Q3
$2.2M Buy
37,002
+4,400
+13% +$262K ﹤0.01% 1567
2020
Q2
$2.28M Buy
32,602
+239
+0.7% +$16.7K ﹤0.01% 1495
2020
Q1
$1.47M Buy
32,363
+6,399
+25% +$290K ﹤0.01% 1578
2019
Q4
$1.69M Sell
25,964
-6,311
-20% -$411K ﹤0.01% 1710
2019
Q3
$2M Sell
32,275
-1,109
-3% -$68.9K ﹤0.01% 1539
2019
Q2
$2.38M Buy
33,384
+4,928
+17% +$351K ﹤0.01% 1456
2019
Q1
$2.23M Buy
28,456
+5,934
+26% +$465K ﹤0.01% 1421
2018
Q4
$1.91M Buy
+22,522
New +$1.91M ﹤0.01% 1373
2018
Q3
Sell
-9,264
Closed -$1.2M 2002
2018
Q2
$1.2M Sell
9,264
-192
-2% -$24.8K ﹤0.01% 994
2018
Q1
$968K Sell
9,456
-1,335
-12% -$137K ﹤0.01% 964
2017
Q4
$922K Buy
10,791
+123
+1% +$10.5K ﹤0.01% 1239
2017
Q3
$905K Buy
10,668
+1,295
+14% +$110K ﹤0.01% 1204
2017
Q2
$709K Buy
9,373
+137
+1% +$10.4K ﹤0.01% 1336
2017
Q1
$610K Buy
9,236
+511
+6% +$33.7K ﹤0.01% 1424
2016
Q4
$551K Buy
8,725
+994
+13% +$62.8K ﹤0.01% 1455
2016
Q3
$492K Sell
7,731
-419
-5% -$26.7K ﹤0.01% 1573
2016
Q2
$606K Buy
8,150
+427
+6% +$31.8K ﹤0.01% 1564
2016
Q1
$516K Buy
7,723
+1,317
+21% +$88K ﹤0.01% 1617
2015
Q4
$433K Buy
6,406
+1,031
+19% +$69.7K ﹤0.01% 1670
2015
Q3
$287K Buy
5,375
+2,095
+64% +$112K ﹤0.01% 1857
2015
Q2
$206K Buy
+3,280
New +$206K ﹤0.01% 2120
2015
Q1
Sell
-692
Closed -$23K 2249
2014
Q4
$23K Buy
692
+46
+7% +$1.53K ﹤0.01% 1688
2014
Q3
$19K Buy
646
+340
+111% +$10K ﹤0.01% 1903
2014
Q2
$12K Buy
306
+142
+87% +$5.57K ﹤0.01% 1956
2014
Q1
$7K Buy
+164
New +$7K ﹤0.01% 2007